CytomX Therapeutics (CTMX) Earnings
|
Expand Research on CTMX
| Next EPS Date | 8/6/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +96.7% | Revenue Growth Rate | -40.2% |
| Average % Move 1-Wk after EPS | -7.4% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/6/26  |
Q226 | N/A | -$0.08 | N/A | N/A | $11.19M | N/A | N/A | N/A | ||
| 5/7/26 |
Q126 | -$0.10 | -$0.12 | +$0.02 | $10.26M | $4.64M | N/A |  | | Details | |
| 5/4/26 |
Q126 | N/A | -$0.12 | N/A | N/A | $4.64M | N/A | N/A | N/A | ||
| 5/1/26 |
Q126 | N/A | -$0.12 | N/A | N/A | $4.64M | N/A | N/A | N/A | ||
| 4/30/26 |
Q126 | N/A | -$0.12 | N/A | N/A | $4.64M | N/A | N/A | N/A | ||
| 3/16/26 |
Q425 | N/A | -$0.09 | N/A | N/A | $9.88M | N/A | N/A | N/A | ||
| 3/4/26 |
Q425 | N/A | -$0.09 | N/A | N/A | $9.88M | N/A | N/A | N/A | ||
| 11/6/25 | Q325 | -$0.09 | -$0.05 | -$0.04 | $5.9M | $11.84M | N/A | | | Details |
